Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Axsome Thera (AXSM)

Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,647,217
  • Shares Outstanding, K 47,496
  • Annual Sales, $ 270,600 K
  • Annual Income, $ -239,240 K
  • 60-Month Beta 1.13
  • Price/Sales 13.62
  • Price/Cash Flow N/A
  • Price/Book 25.58
Trade AXSM with:

Options Overview Details

View History
  • Implied Volatility 40.85% ( +0.50%)
  • Historical Volatility 38.30%
  • IV Percentile 7%
  • IV Rank 14.96%
  • IV High 66.84% on 10/24/23
  • IV Low 36.27% on 05/16/24
  • Put/Call Vol Ratio 1.31
  • Today's Volume 275
  • Volume Avg (30-Day) 830
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 27,740
  • Open Int (30-Day) 21,723

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.32
  • Number of Estimates 8
  • High Estimate -0.91
  • Low Estimate -1.67
  • Prior Year -1.00
  • Growth Rate Est. (year over year) -32.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.53 +6.69%
on 04/25/24
79.13 -6.26%
on 05/21/24
+1.10 (+1.51%)
since 04/23/24
3-Month
65.50 +13.25%
on 04/19/24
84.68 -12.40%
on 02/27/24
-4.76 (-6.03%)
since 02/23/24
52-Week
55.02 +34.82%
on 11/13/23
98.40 -24.61%
on 02/12/24
+2.36 (+3.29%)
since 05/23/23

Most Recent Stories

More News
3 Monster Stocks in the Making You Can Buy Right Now

These stocks might not be small for too much longer.

GS : 458.15 (-0.91%)
LLY : 808.45 (+0.69%)
ALT : 7.39 (-6.34%)
AXSM : 74.18 (-3.40%)
VKTX : 61.57 (-2.29%)
Prediction: These 2 Growth Stocks Could Triple By 2030

These companies have a habit of silencing the bears.

AXSM : 74.18 (-3.40%)
SHOP : 57.64 (-1.81%)
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

AXSM earnings call for the period ending March 31, 2024.

AXSM : 74.18 (-3.40%)
Axsome: Q1 Earnings Snapshot

Axsome: Q1 Earnings Snapshot

AXSM : 74.18 (-3.40%)
Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?

Stocks that work for billionaires aren't necessarily appropriate for every investor.

PLTR : 20.72 (-2.13%)
AXSM : 74.18 (-3.40%)
TMDX : 137.53 (+0.41%)
HTGC : 19.04 (-1.35%)
MO : 45.64 (-1.47%)
2 Under-the-Radar Growth Stocks to Consider

Don't ignore these innovative companies.

MDGL : 234.85 (-0.09%)
AXSM : 74.18 (-3.40%)
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

The price could be right for these three biopharma stocks.

AXSM : 74.18 (-3.40%)
CRSP : 55.73 (-1.88%)
PFE : 28.69 (-3.07%)
3 Biotech Stocks to Buy and Hold for the Next 10 Years

There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon.

CRSP : 55.73 (-1.88%)
AXSM : 74.18 (-3.40%)
AMGN : 306.50 (-0.94%)
Axsome Therapeutics (AXSM) Q4 2023 Earnings Call Transcript

AXSM earnings call for the period ending December 31, 2023.

AXSM : 74.18 (-3.40%)
Enpro, Axsome Therapeutics fall; Walmart, Medtronic rise, Tuesday, 2/20/2024

Stocks that traded heavily or had substantial price changes on Tuesday: Enpro, Axsome Therapeutics fall; Walmart, Medtronic rise

AXSM : 74.18 (-3.40%)
TCMD : 12.78 (-1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

See More

Key Turning Points

3rd Resistance Point 79.15
2nd Resistance Point 78.15
1st Resistance Point 76.16
Last Price 74.18
1st Support Level 73.17
2nd Support Level 72.17
3rd Support Level 70.18

See More

52-Week High 98.40
Fibonacci 61.8% 81.83
Fibonacci 50% 76.71
Last Price 74.18
Fibonacci 38.2% 71.59
52-Week Low 55.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar